To view this email as a web page, click here.
 
Dermatology Times
Improving clinical trial recruitment
Digital recruitment for clinical studies may be more effective than traditional methods, according to a new study.
ADVERTISEMENT
 
A critique of social media recruitment for clinical trials
In this article, Katja Reuter, Ph.D. reviews a study by Katz and colleagues on the effectiveness of using digital platforms to recruit for an atopic dermatitis study. See what she has to say.
 
From our Latest Issue
 
Dermatology Times cover
FDA says start with pediatric patients in atopic dermatitis trials
 
Fast-track designation for atopic dermatitis drug
 
A look at drug development from bench to pharmacy
 
ADVERTISEMENT
What can be done for the millions of patients affected by acne annually?
Approximately 40% of acne patients have scars — and scarring can occur in any severity of acne. Watch this video to learn more about how a decrease in acne lesions can lead to a decrease in acne scars, even in moderate to severe acne patients.
 
JOB OPPORTUNITIES
 
AZ - Integrated Dermatology
CA - Integrated Dermatology
CO - Leavitt Management Group
CO-Integrated Dermatology
CT - Integrated Dermatology
District of Columbia-Integrated Dermatology
FL - Leavitt Management Group
FL - Leavitt Management Group
FL - Leavitt Management Group
FL - Leavitt Management Group
GA - Leavitt Management Group
ID - Integrated Dermatology
MA - Berkshire Health Systems
MA - Integrated Dermatology
MD - Integrated Dermatology
MI - Leavitt Management Group
MI - Leavitt Management Group
MI - Leavitt Management Group
MS - Integrated Dermatology
National - Integrated Dermatology
ND-Altru Health System
NJ - Integrated Dermatology
NV - Integrated Dermatology
PA - Milton S Hershey Medical Center
PA - Leavitt Management Group
PA - Milton S Hershey Medical Center
RI - Leavitt Management Group
TN-Integrated Dermatology
VA - Integrated Dermatology
VT - Pariser Dermatology Specialists
VT - Integrated Dermatology
WY-Leavitt Management Group
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.